Personalised medicine in melanoma

ESMO met with Prof. Reinhard Dummer, a Vice-chairman of the Department of Dermatology in the Cancer Unit at University Hospital in Zurich, Switzerland to discuss on how deeper understanding of molecular biology is relevant for treatment decision in patients with diverse group of melanomas, progress in research of biomarkers, diagnostics and clinical benefit observed from the latest treatment advances. Read the short interview here.